Brown Advisory Portfolio holdings
AUM
$76B
This Quarter Return
+6.23%
1 Year Return
+20.26%
3 Year Return
+97.64%
5 Year Return
+145.01%
10 Year Return
+460.18%
AUM
$31.7B
AUM Growth
+$31.7B
(+1.9%)
Cap. Flow
-$618M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
27.6%
Holding
998
New
64
Increased
422
Reduced
342
Closed
73
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$349M |
| 2 |
Amphenol
APH
|
$278M |
| 3 |
TripAdvisor
TRIP
|
$262M |
| 4 |
Enovis
ENOV
|
$121M |
| 5 |
Booking.com
BKNG
|
$70.9M |
Top Sells
| 1 |
Accenture
ACN
|
$295M |
| 2 |
Fluor
FLR
|
$281M |
| 3 |
CVD
COVANCE INC.
CVD
|
$225M |
| 4 |
Fossil Group
FOSL
|
$158M |
| 5 |
Gilead Sciences
GILD
|
$144M |
Sector Composition
| 1 | Technology | 19.35% |
| 2 | Healthcare | 18.74% |
| 3 | Financials | 13.49% |
| 4 | Consumer Staples | 9.18% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Bristol-Myers Squibb
BMY
$96B
| $366M | 1.16% |
6,206,910
+5,919,161
| +2,057% | +$349M |
|
|
ANSS
27
DELISTED
Ansys
ANSS
| $332M | 1.05% |
4,048,107
-196,751
| -5% | -$16.1M |
|
|
CVD
28
DELISTED
COVANCE INC.
CVD
| $323M | 1.02% |
3,109,194
-2,163,808
| -41% | -$225M |
|
|
DISCK
29
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $290M | 0.91% |
8,598,194
+568,621
| +7% | +$19.2M |
|
|
NATI
30
DELISTED
National Instruments Corp
NATI
| $283M | 0.89% |
9,113,407
-433,594
| -5% | -$13.5M |
|
|
31
TripAdvisor
TRIP
$2.02B
| $262M | 0.83% |
+3,512,314
| New | +$262M |
|
32
Mastercard
MA
$538B
| $258M | 0.81% |
2,993,198
+32,644
| +1% | +$2.81M |
|
33
Exxon Mobil
XOM
$487B
| $254M | 0.8% |
2,746,676
-169,074
| -6% | -$15.6M |
|
|
N
34
DELISTED
Netsuite Inc
N
| $242M | 0.76% |
2,220,738
+633,889
| +40% | +$69.2M |
|
|
DISCA
35
DELISTED
Discovery, Inc. Series A Common Stock
DISCA
| $236M | 0.74% |
6,837,748
-369,222
| -5% | -$12.7M |
|
36
Wells Fargo
WFC
$263B
| $231M | 0.73% |
4,212,238
+174,138
| +4% | +$9.55M |
|
37
Best Buy
BBY
$15.6B
| $217M | 0.68% |
5,559,952
-244,949
| -4% | -$9.55M |
|
38
Microsoft
MSFT
$3.75T
| $213M | 0.67% |
4,575,330
-71,686
| -2% | -$3.33M |
|
39
Kinder Morgan
KMI
$60B
| $212M | 0.67% |
5,006,450
+456,310
| +10% | +$19.3M |
|
40
Berkshire Hathaway Class B
BRK.B
$1.08T
| $195M | 0.61% |
1,298,354
+38,340
| +3% | +$5.76M |
|
41
JPMorgan Chase
JPM
$829B
| $191M | 0.6% |
3,057,286
+63,917
| +2% | +$4M |
|
42
Canadian National Railway
CNI
$60.4B
| $175M | 0.55% |
2,544,786
+27,485
| +1% | +$1.89M |
|
43
Teva Pharmaceuticals
TEVA
$21.5B
| $166M | 0.52% |
2,889,321
+25,825
| +0.9% | +$1.49M |
|
44
Occidental Petroleum
OXY
$47.3B
| $161M | 0.51% |
2,002,197
+66,506
| +3% | +$5.36M |
|
|
45
Fossil Group
FOSL
$165M
| $158M | 0.5% |
1,424,207
-1,430,831
| -50% | -$158M |
|
46
Walt Disney
DIS
$213B
| $143M | 0.45% |
1,516,372
+26,829
| +2% | +$2.53M |
|
|
47
Enovis
ENOV
$1.77B
| $143M | 0.45% |
2,766,672
+2,351,965
| +567% | +$121M |
|
48
Lowe's Companies
LOW
$145B
| $137M | 0.43% |
1,997,716
+53,063
| +3% | +$3.65M |
|
49
Merck
MRK
$214B
| $130M | 0.41% |
2,291,796
-177,432
| -7% | -$10.1M |
|
|
50
Accenture
ACN
$162B
| $129M | 0.41% |
1,448,940
-3,301,863
| -70% | -$295M |
|